← FDA Drug Approvals (Drugs@FDA)

RIBAVIRIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BEXIMCO PHARMS USA · Approved 2014-08-12

Drug application

FDA Application #

ANDA202546

Application type

Abbreviated New Drug Application (Generic)

Brand name

RIBAVIRIN

Generic name

Ribavirin

Active ingredients

RIBAVIRIN

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

BEXIMCO PHARMS USA

First approval

2014-08-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown